Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPASS trial for prevention of contrast-induced acute kidney injury
NL-OMON29471Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium bicarbonate in contrast-induced nephropathy (CIN) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Mean relative increase in serum creatinine. Started Apr 2013; status: active, not recruiting.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NL-OMON29471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29471.